Recombinant Tropheryma whipplei (Dimethylallyl)adenosine tRNA methylthiotransferase MiaB (miaB)

Shipped with Ice Packs
In Stock

Description

Introduction

Recombinant Tropheryma whipplei (Dimethylallyl)adenosine tRNA methylthiotransferase MiaB (miaB) is an enzyme produced in yeast with high purity that is involved in tRNA modification . Specifically, MiaB is a methylthiotransferase that modifies tRNA by catalyzing the thiomethylation of N6-isopentenyladenosine (i6A) to 2-methylthio-N6-isopentenyladenosine (ms2i6A) . This modification is crucial for proper tRNA function and, consequently, protein synthesis.

Tropheryma whipplei and MiaB

Tropheryma whipplei is a bacterium responsible for Whipple's disease, a rare systemic infectious disease . T. whipplei is a poorly known pathogen with a small genome of approximately 0.92 Mb . Understanding the function and characteristics of its proteins, like MiaB, is essential for developing potential therapeutic strategies.

Function of MiaB

MiaB is essential for the 2-methylthio modification of isopentenylated adenosine at position 37 in tRNA . This modification is important for maintaining the structural integrity and decoding ability of tRNA. Specifically, MiaB catalyzes the formation of 2-methylthio-N6-isopentenyladenosine (ms2i6A) from N6-isopentenyladenosine (i6A) .

MiaB in Streptomyces albidoflavus J1074

Research indicates that in Streptomyces albidoflavus J1074, the MiaB ortholog, when overexpressed, yields ms2A in a ΔmiaA background, which suggests a non-canonical function .

Importance of tRNA Modifications

tRNA modifications, like those catalyzed by MiaB, play a crucial role in various cellular processes:

  • tRNA Folding: Modifications can influence tRNA folding and stability .

  • Codon Recognition: They can affect the accuracy and efficiency of codon recognition during translation.

  • Cellular Fitness: Modifications contribute to cellular fitness and survival under stress conditions .

Related Research: TrmA as a tRNA Chaperone

TrmA, another methyltransferase, facilitates tRNA folding . TrmA methylates U54 to m5U54, a modification found in almost all bacterial and eukaryotic tRNAs . TrmA requires the opening of the T arm for modification of U54, which unfolds the tRNA . Studies on TrmA in E. coli have shown that it functions as a tRNA chaperone, supporting a functional link between RNA modification and folding .

Potential Applications

Recombinant MiaB can be used in biochemical assays, structural studies, and drug discovery efforts. It serves as a valuable tool for understanding the mechanism of tRNA modification and its role in bacterial physiology.

Product Information

Recombinant Tropheryma whipplei (Dimethylallyl)adenosine tRNA methylthiotransferase MiaB (miaB) is available for purchase as a recombinant protein produced in Yeast . The protein has the following characteristics:

  • Product Code: CSB-YP774458TIV or CSB-EP774458TIV-B

  • Abbreviation: miaB

  • Purity: >85% (SDS-PAGE)

  • Source Organism: Tropheryma whipplei (strain TW08/27) (Whipple's bacillus)

  • UniProt No.: Q83HG3

  • Sequence:
    MTYTVRTYGC QMNVHDSERI AGVLEDEGYV KSGSDDADVV VLNTCAVREN
    ADNRFYGNLG QLLQKKNNGR IRQIAVGGCL AQKDRHKIFE KAPWVDVVFG
    THNLGSLPAL LRRSRHNKTA EIEIKDFLET FPSSLPVRRE SNYS

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order remarks; we will accommodate your request to the best of our ability.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: All protein shipments include standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a guideline for your preparations.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. If you require a specific tag type, please inform us, and we will prioritize its development.
Synonyms
miaB; TW627tRNA-2-methylthio-N(6)-dimethylallyladenosine synthase; EC 2.8.4.3,; Dimethylallyl)adenosine tRNA methylthiotransferase MiaB; tRNA-i(6)A37 methylthiotransferase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-470
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Tropheryma whipplei (strain TW08/27) (Whipple's bacillus)
Target Names
miaB
Target Protein Sequence
MTYTVRTYGC QMNVHDSERI AGVLEDEGYV KSGSDDADVV VLNTCAVREN ADNRFYGNLG QLLQKKNNGR IRQIAVGGCL AQKDRHKIFE KAPWVDVVFG THNLGSLPAL LRRSRHNKTA EIEIKDFLET FPSSLPVRRE SNYSAWVSIS VGCNNTCTFC IVPSLRGKER DRRPGDILAE ISALVSEGVL EVTLLGQNVN TYGVEFGDRS AFASLLRKAG AIEGLERLKF TSPHPAAFTS DVIDAMHDTQ AVLPQLHMPL QSGSDRILRA MRRSYRAGKF LKIISEARNK IPNIAITTDI IVGFPGETEE DFQDTLNLVA EVRFASAFTF QYSPRPGTPA ASMPNQIPGD IVQERYDRLL DLQNRIALEE NRKLIGKEVE LLVTVGGRKD SMLDNRYTGR TPCGRLVHFS CLHQLRPGDF ATVKIIYAAP YHLIGDNALT VRRTPAGDVW IQKNDTRSAQ LVSLGMPRIR
Uniprot No.

Target Background

Function
This enzyme catalyzes the methylthiolation of N6-(dimethylallyl)adenosine (i6A), producing 2-methylthio-N6-(dimethylallyl)adenosine (ms2i6A) at position 37 in tRNAs that recognize codons beginning with uridine.
Database Links

KEGG: tws:TW627

Protein Families
Methylthiotransferase family, MiaB subfamily
Subcellular Location
Cytoplasm.

Q&A

How does MiaB contribute to T. whipplei pathogenicity?

While direct evidence is still emerging, research suggests that MiaB likely contributes to T. whipplei pathogenicity through several mechanisms. Similar to findings in other bacteria, MiaB-mediated tRNA modifications may influence the expression of virulence factors. In P. aeruginosa, for example, MiaB has been shown to regulate Type III Secretion System (T3SS) gene expression independent of its tRNA modification function . In T. whipplei, MiaB might similarly regulate virulence genes, potentially influencing bacterial survival within macrophages by modulating phagosome maturation pathways. This hypothesis is supported by observations that T. whipplei can replicate within macrophages by altering phagosomal trafficking .

What is the relationship between MiaB and the two-step tRNA modification process?

MiaB operates in conjunction with MiaA in a two-step tRNA modification process at position 37 (A37):

EnzymeModification StepSubstrateProductFunction
MiaAFirst stepA37i⁶A (isopentenyladenosine)Addition of prenyl group to N⁶-nitrogen of A37
MiaBSecond stepi⁶Ams²i⁶AAddition of methylthio group

This modification process represents one of the most common tRNA modifications and is highly conserved across bacterial species. The complete modification enhances codon-anticodon interactions during translation, potentially affecting the efficiency and accuracy of protein synthesis under different environmental conditions .

What are the optimal conditions for expressing recombinant T. whipplei MiaB?

The optimal expression of recombinant T. whipplei MiaB typically requires careful consideration of several experimental parameters:

  • Expression System: E. coli BL21(DE3) or similar strains are recommended due to their reduced protease activity.

  • Temperature: Lower induction temperatures (16-20°C) often yield higher amounts of soluble protein.

  • Induction Conditions: 0.1-0.5 mM IPTG for 16-18 hours.

  • Buffer Composition: Tris-HCl (50 mM, pH 8.0), NaCl (300 mM), and reducing agents like DTT (1 mM) or β-mercaptoethanol.

  • Additives: Including 10% glycerol and iron-sulfur cluster stabilizing agents improves enzyme stability.

For experimental validation, activity assays should be performed using purified tRNA substrates, analyzing the conversion of i⁶A to ms²i⁶A by techniques such as HPLC or mass spectrometry. Similar to methodologies used in P. aeruginosa MiaB studies, these approaches can verify the enzymatic activity of recombinant T. whipplei MiaB .

How can Bayesian optimal experimental design improve MiaB functional studies?

Bayesian optimal experimental design (OED) offers significant advantages for complex MiaB functional studies by enabling adaptive experimental approaches that maximize information gain while minimizing resource expenditure. This methodology is particularly valuable when investigating the multifaceted roles of MiaB in bacterial physiology.

The implementation of Bayesian OED for MiaB studies typically follows this workflow:

  • Model Formulation: Develop a probabilistic model of MiaB function incorporating prior knowledge.

  • Design Optimization: Identify experimental conditions that maximize expected information gain.

  • Data Collection: Conduct experiments under the optimized conditions.

  • Bayesian Inference: Update the model based on experimental results.

  • Iterative Refinement: Use updated knowledge to inform subsequent experimental designs.

This adaptive approach is especially beneficial when exploring the relationship between MiaB's enzymatic activity and bacterial phenotypes under various environmental conditions. Recent advances in black-box variational inference have made these methods more accessible for practical laboratory implementation3.

What techniques are most effective for studying MiaB interaction with host immune responses?

When investigating how T. whipplei MiaB potentially influences host immune responses, researchers should consider these methodological approaches:

  • Recombinant Protein Studies: Expose macrophages to purified recombinant MiaB and assess changes in cytokine production, particularly IL-16 levels, using ELISA or cytokine arrays.

  • Gene Knockout Experiments: Create MiaB-deficient T. whipplei strains and compare their interactions with macrophages to wild-type strains, focusing on:

    • Bacterial replication rates (qPCR-based quantification)

    • Phagolysosomal colocalization (immunofluorescence microscopy)

    • Host gene expression changes (RNA-seq or microarray analysis)

  • Cross-Species Comparative Analysis: Compare immune responses to T. whipplei MiaB with responses to MiaB from other bacterial species to identify unique immunomodulatory properties.

These techniques would help determine whether MiaB influences IL-16-mediated inhibition of phagosome maturation, which has been shown to promote T. whipplei replication in macrophages .

How does MiaB in T. whipplei differ structurally and functionally from its homologs in other bacterial species?

Structural and functional differences between T. whipplei MiaB and its homologs in other bacteria represent an important area of investigation. Comparative analysis reveals several notable distinctions:

FeatureT. whipplei MiaBP. aeruginosa MiaBE. coli MiaB
Domain ArchitectureRadical SAM domain, TRAM domain, Fe-S binding motifsSimilar core domains with unique C-terminal regionCanonical domain structure
Iron-Sulfur ClusterLikely contains two [4Fe-4S] clustersContains two [4Fe-4S] clustersContains two [4Fe-4S] clusters
Substrate SpecificityPotentially narrower tRNA specificityBroader tRNA recognitionWell-characterized specificity
Non-canonical FunctionsPossible unique roles in immune evasionRegulates T3SS expression independent of tRNA modificationPrimarily involved in tRNA modification

The unique aspects of T. whipplei MiaB may contribute to the organism's distinctive pathogenicity profile. Particularly noteworthy is the possibility that, similar to P. aeruginosa MiaB, T. whipplei MiaB might regulate virulence factors independently of its tRNA modification activity, potentially through direct or indirect interaction with transcriptional regulators .

What role does MiaB play in T. whipplei's ability to evade phagolysosomal destruction in macrophages?

Evidence suggests that T. whipplei's ability to survive within macrophages may be linked to MiaB activity, though the exact mechanisms remain under investigation. Research on T. whipplei infection of macrophages shows that the bacterium can inhibit phagosome maturation, with only 56±6% of T. whipplei phagosomes colocalizing with cathepsin D initially, decreasing to 21±2% by day 12 post-infection .

MiaB may contribute to this process through several potential mechanisms:

  • Regulation of Bacterial Factors: MiaB might influence the expression of bacterial proteins that interfere with phagolysosomal fusion or maturation.

  • Modulation of Host Signaling: Similar to how MiaB in P. aeruginosa independently regulates signaling pathways , T. whipplei MiaB might affect host cell signaling cascades involved in phagosome maturation.

  • Interaction with IL-16 Pathway: Given that IL-16 promotes T. whipplei replication by inhibiting phagosome maturation , MiaB could potentially enhance IL-16 production or signaling in infected cells.

To test these hypotheses, researchers should compare phagolysosomal colocalization rates between wild-type and MiaB-deficient T. whipplei strains, combining immunofluorescence microscopy with transcriptomic and proteomic analyses of both the bacterium and host cells.

How can contradictory findings in MiaB functional studies be reconciled?

Researchers investigating T. whipplei MiaB function may encounter seemingly contradictory results across different experimental systems. These discrepancies can be systematically addressed through:

  • Contextual Analysis: Evaluate whether differences arise from:

    • Experimental conditions (in vitro vs. ex vivo vs. in vivo)

    • Cell types or models used

    • Bacterial strains and their genetic backgrounds

  • Methodological Reconciliation:

    • Implement Bayesian hierarchical modeling to integrate data from diverse sources

    • Use meta-analytical approaches to quantify uncertainty across studies

    • Apply causal inference methods to distinguish direct from indirect effects

  • Biological Complexity Recognition:

    • Consider that MiaB may have context-dependent functions

    • Investigate potential regulatory feedback loops

    • Examine interactions with other cellular systems

For example, if one study suggests MiaB directly affects phagosome maturation while another indicates an indirect effect through tRNA modification, both findings could be valid under different conditions or represent different aspects of a complex biological network. Bayesian optimal experimental design can be particularly useful for resolving such contradictions by systematically exploring the parameter space of possible mechanisms3.

What statistical approaches are most appropriate for analyzing differential gene expression in MiaB-dependent pathways?

The analysis of differential gene expression in MiaB-dependent pathways requires robust statistical approaches tailored to the complexities of bacterial transcriptomics:

  • Preprocessing and Normalization:

    • Implement RNA spike-in controls for cross-sample normalization

    • Apply variance stabilizing transformations appropriate for bacterial expression data

    • Account for batch effects using ComBat or similar methods

  • Differential Expression Analysis:

    • For experiments with complex designs, use linear models (limma) with empirical Bayes moderation

    • Apply false discovery rate control using the Benjamini-Hochberg procedure

    • Consider time-course specific methods for temporal expression patterns

  • Pathway Analysis:

    • Employ Gene Ontology enrichment analysis as demonstrated in studies of P. aeruginosa MiaB, where GO biological processes revealed significant functional differences between wild-type and MiaB-deficient responses

    • Utilize bacterial pathway databases for functional interpretation

    • Consider transcription factor analysis to identify regulatory networks

For example, in P. aeruginosa, microarray analysis of MiaB-dependent gene expression revealed 356 significantly modulated probes in wild-type bacteria compared to 273 in MiaB-deficient strains, with only 42 probes commonly modulated in both conditions. Gene Ontology analysis at level 5 identified 2 over-represented GO terms in wild-type bacteria versus 13 in MiaB-deficient bacteria, with 10 of these linked to immune response .

How should researchers interpret changes in tRNA modification profiles when studying MiaB function?

Interpreting changes in tRNA modification profiles requires careful consideration of both direct enzymatic effects and broader biological implications:

  • Analytical Framework:

    • Distinguish between changes in i⁶A accumulation versus ms²i⁶A reduction

    • Evaluate modification changes in the context of specific tRNA species

    • Consider position-specific effects beyond A37

  • Functional Interpretation Guidelines:

ObservationPrimary InterpretationSecondary Considerations
Decreased ms²i⁶A with normal i⁶A levelsDirect MiaB enzymatic deficiencyPossible cofactor limitation
Decreased ms²i⁶A with increased i⁶AMiaB functional defect with substrate accumulationPotential feedback inhibition
Global tRNA modification changesBroader stress responseRegulatory network effects
tRNA species-specific changesSelective regulation of specific genetic circuitsCodon usage implications
  • Translation Impact Assessment:

    • Analyze changes in translation efficiency using ribosome profiling

    • Examine codon-specific translational pausing

    • Correlate modification changes with proteome alterations

The relationship between tRNA modification dynamics and bacterial adaptation to environmental stresses represents a crucial aspect of MiaB function, as these modifications have been described as an adaptive strategy for changing proteome profiles in response to different environmental stimuli .

What novel approaches might advance our understanding of MiaB's role in T. whipplei pathogenesis?

Several innovative approaches could significantly advance our understanding of MiaB's role in T. whipplei pathogenesis:

  • Cryo-electron Microscopy for Structural Analysis:

    • Determine the 3D structure of T. whipplei MiaB at atomic resolution

    • Compare structural features with MiaB homologs from other bacterial species

    • Identify potential binding sites for inhibitors or regulatory molecules

  • Single-cell Transcriptomics:

    • Profile gene expression in individual T. whipplei cells within infected tissues

    • Identify subpopulations with differential MiaB activity

    • Correlate single-cell bacterial transcriptomes with host cell responses

  • CRISPR Interference/Activation Systems:

    • Develop conditional knockdown/overexpression systems for MiaB in T. whipplei

    • Create libraries of T. whipplei mutants with varying levels of MiaB activity

    • Screen for phenotypes related to intracellular survival and virulence

  • Host-pathogen Protein Interactome Mapping:

    • Identify host proteins that interact with T. whipplei MiaB

    • Investigate whether MiaB is secreted or exposed to the host environment

    • Determine if MiaB directly modulates host signaling pathways

  • Bayesian Experimental Design:

    • Implement adaptive experimental design strategies to efficiently explore MiaB function

    • Develop probabilistic models that integrate multiple data types

    • Use information-theoretic approaches to identify critical experiments3

These approaches would complement existing research methodologies and potentially reveal new aspects of MiaB function in T. whipplei pathogenesis.

How might inhibitors of T. whipplei MiaB be rationally designed for research purposes?

The rational design of T. whipplei MiaB inhibitors for research applications requires a systematic approach:

  • Structure-based Design Strategy:

    • Focus on unique structural features that distinguish T. whipplei MiaB from human homologs

    • Target active site residues involved in S-adenosylmethionine (SAM) binding

    • Design compounds that interfere with iron-sulfur cluster assembly or function

  • Potential Inhibitor Classes:

Inhibitor ClassTarget SiteMechanism of ActionResearch Application
SAM AnalogsSAM binding pocketCompetitive inhibitionProbe MiaB catalytic mechanism
Iron chelatorsFe-S clustersDisrupt cluster integrityStudy Fe-S dependency
Substrate mimicstRNA binding sitePrevent substrate bindingInvestigate substrate recognition
Allosteric inhibitorsRegulatory domainsAlter protein conformationExamine regulatory mechanisms
  • Validation Approaches:

    • Enzymatic assays with purified recombinant MiaB

    • Cellular assays measuring changes in tRNA modification profiles

    • Bacterial survival assays in macrophage infection models

  • Selectivity Considerations:

    • Assess cross-reactivity with human radical SAM enzymes

    • Test effects on commensal bacteria with MiaB homologs

    • Screen for off-target effects on host cell functions

Such research tools would be invaluable for dissecting the specific contributions of MiaB to T. whipplei pathogenesis and could provide insights into the relationship between tRNA modification and bacterial virulence mechanisms .

What are the most promising applications of adaptive experimental design in studying T. whipplei MiaB function?

Adaptive experimental design offers several promising applications for investigating T. whipplei MiaB function:

  • Optimizing Enzyme Characterization:

    • Sequential refinement of reaction conditions to maximize enzymatic activity

    • Efficient mapping of substrate specificity across different tRNA species

    • Systematic exploration of cofactor requirements and inhibitor screening

  • Host-Pathogen Interaction Studies:

    • Identifying key experimental conditions that reveal MiaB's role in macrophage infection

    • Optimizing timepoints for sampling during infection progression

    • Determining critical host factors that interact with MiaB-dependent processes

  • In vivo Model Development:

    • Efficiently identifying appropriate animal models for studying T. whipplei MiaB function

    • Optimizing infection parameters to reveal MiaB-dependent phenotypes

    • Designing treatment regimens for testing MiaB inhibitors

The implementation of Bayesian optimal experimental design is particularly valuable in these contexts as it enables:

  • Formalization of prior knowledge through probabilistic models

  • Quantification of expected information gain from potential experiments

  • Sequential updating of experimental designs based on accumulated data

  • Principled handling of uncertainty in complex biological systems3

These approaches can significantly accelerate research progress while reducing resource expenditure, particularly important when working with challenging organisms like T. whipplei that have specialized growth requirements and limited genetic manipulation tools.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.